CKD KK
6407
ISIN JP3346800000 / Valor 761590
CKD KK
UMushroom community rating:
About company
Fresenius Medical Care is a global leader in providing products and services for individuals with renal diseases, particularly focusing on dialysis treatment. The company supplies essential dialysis products, including dialysis machines and dialyzers, to approximately 4.1 million patients worldwide. In addition to its core business within the Renal Care Continuum, Fresenius Medical Care is expanding into complementary areas and critical care. With a global workforce, the company is dedicated to addressing the diverse needs of its patients and improving their quality of life through innovative healthcare solutions.
Summarized from source with an LLMView SourceSector: IndustrialsLatest Results (20.08.2024):
Revenue
CKD KK reported consolidated sales of KRW 879,781 million for the fourth quarter of 2023, a slight decrease from KRW 908,963 million in the same quarter of the previous year.
Operating Income
For the fourth quarter of 2023, CKD KK achieved an operating income of KRW 17,005 million, a significant improvement compared to the operating loss of KRW 32,878 million reported in the fourth quarter of 2022.
Net Income
CKD KK's net income for the fourth quarter of 2023 was KRW 40,575 million, a notable turnaround from the net loss of KRW 22,664 million in the same period of the previous year.
Liabilities
As of December 31, 2023, CKD KK's total consolidated liabilities stood at KRW 632,519 million, up from KRW 577,829 million at the end of 2022, reflecting an increase in both current and non-current liabilities.
Stockholders' Equity
CKD KK's total consolidated stockholders' equity was KRW 823,485 million as of December 31, 2023, showing an increase from KRW 798,544 million at the end of the previous year, driven by higher retained earnings.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1103 M
Market cap (USD)
225,500
Daily traded volume (Shares)
2551 / 2518
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
